Literature DB >> 21302350

Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and age of onset in schizophrenia: a combined analysis of independent samples.

Peter Saetre1, Maria Vares, Thomas Werge, Ole A Andreassen, Tadao Arinami, Hiroki Ishiguro, Shinichiro Nanko, Ene Choo Tan, Doug Hyun Han, Joshua L Roffman, Jan-Willem Muntjewerff, Pawel P Jagodzinski, Bartosz Kempisty, Joanna Hauser, Elisabet Vilella, Elitza Betcheva, Yusuke Nakamura, Björn Regland, Ingrid Agartz, Håkan Hall, Lars Terenius, Erik G Jönsson.   

Abstract

Methylenetetrahydrofolate reductase (MTHFR) is involved in the one-carbon cycle, which is of importance for nucleotide synthesis and methylation of DNA, membranes, proteins and lipids. The MTHFR gene includes two common polymorphisms (rs1801133 or C677T; rs1801131 or A1298C) which both alter enzyme activity. The T-allele of the C677T polymorphism has recently been associated with earlier age at onset of schizophrenia. In the present study we examined the association between the MTHFR C677T and A1298C polymorphisms and age at onset of schizophrenia in twelve samples consisting of 3,213 unrelated schizophrenia patients, including the original Scandinavian sample. There was no consistent relationship between MTHFR C677T, A1298C or combined 677T/1298C carriers and age of onset in schizophrenia when the results of each study were combined using meta-analysis. The present results suggest that the investigated MTHFR polymorphisms do not influence age of onset in schizophrenia.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21302350     DOI: 10.1002/ajmg.b.31160

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  7 in total

1.  Age Matters: an Atypical Association Between Polymorphism of MTHFR and Clinical Phenotypes in Children with Schizophrenia.

Authors:  Lin Wan; Yuhong Li; Yuming Zhou; Rena Li; Yi Zheng
Journal:  J Mol Neurosci       Date:  2019-07-13       Impact factor: 3.444

2.  Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis.

Authors:  Cai-Yun Hu; Zhen-Zhong Qian; Feng-Feng Gong; Shan-Shan Lu; Fang Feng; Yi-Le Wu; Hui-Yun Yang; Ye-Huan Sun
Journal:  J Neural Transm (Vienna)       Date:  2014-06-18       Impact factor: 3.575

3.  Elevated homocysteine level in first-episode schizophrenia patients--the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse.

Authors:  Blazej Misiak; Dorota Frydecka; Ryszard Slezak; Patryk Piotrowski; Andrzej Kiejna
Journal:  Metab Brain Dis       Date:  2014-03-30       Impact factor: 3.584

Review 4.  Methylenetetrahydrofolate reductase and psychiatric diseases.

Authors:  Lin Wan; Yuhong Li; Zhengrong Zhang; Zuoli Sun; Yi He; Rena Li
Journal:  Transl Psychiatry       Date:  2018-11-05       Impact factor: 6.222

5.  Early-Onset Schizophrenia: A Special Phenotype of the Disease Characterized by Increased MTHFR Polymorphisms and Aggravating Symptoms.

Authors:  Lin Wan; Jing Wei
Journal:  Neuropsychiatr Dis Treat       Date:  2021-08-03       Impact factor: 2.570

6.  Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age at onset of schizophrenia: no consistent evidence for an association in the Nordic population.

Authors:  Peter Saetre; Jakob Grove; Anders D Børglum; Ole Mors; Thomas Werge; Ole A Andreassen; Maria Vares; Ingrid Agartz; Lars Terenius; Erik G Jönsson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-10-17       Impact factor: 3.568

7.  MTHFR gene polymorphism and age of onset of schizophrenia and bipolar disorder.

Authors:  Mohamed A El-Hadidy; Hanaa M Abdeen; Sherin M Abd El-Aziz; Mohammad Al-Harrass
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.